SU22AN UNUSUAL HIGH FREQUENCY OF NATURAL FETAL LOSS IN AUTISM SPECTRUM DISORDER

dc.contributor.authorClaudia Lattig
dc.contributor.authorDiana Nuñez
dc.contributor.authorAndrea López
dc.contributor.authorYvonne Gómez
dc.contributor.authorRoberto Chaskel
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T18:02:15Z
dc.date.available2026-03-22T18:02:15Z
dc.date.issued2019
dc.identifier.doi10.1016/j.euroneuro.2018.08.386
dc.identifier.urihttps://doi.org/10.1016/j.euroneuro.2018.08.386
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/67732
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofEuropean Neuropsychopharmacology
dc.sourceUniversidad de Los Andes
dc.subjectMedicine
dc.subjectCefoxitin
dc.subjectCefotaxime
dc.subjectStaphylococcus aureus
dc.subjectNose
dc.subjectMicrobiology
dc.subjectStaphylococcus epidermidis
dc.titleSU22AN UNUSUAL HIGH FREQUENCY OF NATURAL FETAL LOSS IN AUTISM SPECTRUM DISORDER
dc.typearticle

Files